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Temperature disturbances are common in patients with severe traumatic brain injury. The 
possibility of an adaptive, potentially beneficial role for fever in patients with severe brain trauma 
has been dismissed, but without good justification. Fever might, in some patients, confer benefit. 
A cadre of clinicians and scientists met to debate the clinically relevant, but often controversial 
issue about whether raised brain temperature after human traumatic brain injury (TBI) should 
be regarded as “good or bad” for outcome. The objective was to produce a consensus 
document of views about current temperature measurement and pyrexia treatment. Lectures 
were delivered by invited speakers with National and International publication track records 
in thermoregulation, neuroscience, epidemiology, measurement standards and neurocritical 
care. Summaries of the lectures and workshop discussions were produced from transcriptions 
of the lectures and workshop discussions. At the close of meeting, there was agreement 
on four key issues relevant to modern temperature measurement and management and for 
undergirding of an evidence-based practice, culminating in a consensus statement. There is no 
robust scientific data to support the use of hypothermia in patients whose intracranial pressure 
is controllable using standard therapy. A randomized clinical trial is justified to establish if body 
cooling for control of pyrexia (to normothermia) vs moderate pyrexia leads to a better patient 
outcome for TBI patients.
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(Kilpatrick et al., 2000) because of the commonly held view that a 
mild to moderate rise in temperature is harmful (Manno and Farmer, 
2004). We can add a third common assumption that, for all practical 
purposes, body temperature is an adequate surrogate measure of 
brain temperature even though there are well documented observa-
tions showing brain-body dissociation (Mellergard, 1994; Stone et al., 
1995; Henker et al., 1998; Rumana et al., 1998; Childs et al., 2005).
Guidelines for the best approach to temperature measurement 
do not exist. The most recent (2007) Brain Trauma Foundation 
(BTF) recommendations for therapeutic hypothermia after TBI 
(Bullock and Povlishock, 2007) are based on the lowest level of 
evidence only (Cook et al., 1995; also refer to Center for Evidence 
Based Medicine www.cebm-net/). Until we can “close the loop” on 
our understanding of the impact of pyrexia on outcome (good or 
bad in the case of TBI patients; Childs, 2008) treatment will con-
tinue to be underpinned by weak, inconclusive evidence of benefit. 
This paper aims at summarizing current knowledge in the field and 
in particular two clinically relevant issues:
(a) In the critical care setting, what should future recommen-
dations be: direct measurement of brain temperature or to 
continue using body core temperature surrogates?
IntroductIon
PyrexIa after traumatIc braIn Injury: Is It good or bad for 
PatIent outcome?
For patients with severe traumatic brain injury (TBI) temperature 
management is undertaken for two reasons; (a) for neuroprotection 
(b) for control of pyrexia. In the case for cerebral neuroprotection, 
results in rodents provide convincing evidence that if body (or 
brain) temperature is lowered such that animals are rendered hypo-
thermic during a brief period of transient cerebral ischemia, infarct 
size is smaller compared to the “normothermic” or hyperthermic 
animal (Busto et al., 1987; Kim et al., 1996; Yanamoto et al., 1999). 
The starting point to begin hypothermic neuroprotection may well 
be a normal temperature (which in the rat under thermoneutral 
conditions is 38°C Stoner, 1974). Hypothermia holds promise as a 
neuroprotective therapy after ischemic stroke (Lyden et al., 2006) 
but as the role of ischemia remains controversial as a mechanism of 
brain damage after TBI (Coles, 2004; Vespa, et al., 2005) the benefit 
of hypothermia for neuroprotection in this patient group remains 
speculative (Abate et al., 2008).
To date there is no robust evidence that control of pyrexia, using 
antipyretic drugs or body cooling is beneficial after severe TBI. 
Nevertheless current opinion favors treatment for control of pyrexia 
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the role of temPerature In the damaged braIn
In most animal species, the response to local and systemic inflam-
mation and infection is a rise in body temperature. Fever, with its 
long evolutionary history has been shown to confer benefit for the 
host in terms of bacterial killing and increased immunity. Over the 
years, studies have been conducted in numerous species (Kluger, 
1979) and the survival benefit of fever is evident (Romanovsky and 
Szekely, 1998). It is also clear that mortality increases if the febrile 
response to inflammation is prevented or blocked (Griesman and 
Mackowiak, 2002; Schulman et al., 2005).
In patients, fever is a common sign of inflammation and trauma 
and for the most part is widely thought to have a beneficial role 
in “fighting” infection. However, if the injury damages brain (and 
specifically ischemic cells) tolerance to heat is low (Brinnel et al., 
1987). The prevailing view in neurocritical care rather favors the 
opinion that raised temperature after TBI is bad and that low tem-
perature is innocuous and beneficial.
Studies in animals show that below normal temperature pre-
serves, and high temperature accelerates damage in ischemic neu-
rones (Yanamoto et al., 1999). There is evidence to support the 
case for therapeutic neuroprotection by induction of hypothermia 
in ischemic brain (cardiac arrest; Lyon et al., 2010) and neonatal 
hypoxic encephalopathy (Shankaran et al., 2008) but the evidence 
is not as compelling after human stroke (Schwab et al., 1998) and 
the value of mild or moderate hypothermia remains speculative 
in patients with brain trauma (Sydenham et al., 2009). On balance 
therefore, the view is that raised temperature due to fever has bio-
logical benefit if the brain is intact but once damaged (specifically 
by ischemia) any protective benefits of a “true” fever may be out-
weighed by the presumed increased vulnerability of CNS tissue to 
damage by heat (Haveman et al., 2005; Van Der Zee et al., 2008).
The uncertainty about the role of fever after TBI presents a 
dilemma for the clinician. How can appropriate evidence-based 
decisions be made when there is a lack of robust data to under-
pin practice? Which patients should be a priority for treatment of 
pyrexia and which patients are at low risk of temperature-related 
secondary damage? With the increasing interest and use of thera-
peutic hypothermia, even in the absence of clear benefit, at least in 
humans we may now need to question the potential for “good” and 
“bad” effects of deliberate hypothermia, as well as the potentially 
“good” and “bad” effects of fever (Clifton et al., 2001; Hutchinson 
et al., 2008). Since there is an abundant literature on the use of 
therapeutic hypothermia, still without a definitive answer about 
its benefits, it is timely to give thought to the apparently “unthink-
able”; that there may be TBI patients for whom a moderate rise 
in temperature might not be harmful and who might not need 
aggressive temperature control.
temPerature as a marker of secondary braIn damage
Of the many factors contributing to the quality of a patient’s 
outcome after TBI, body temperature has only recently been con-
sidered for its prognostic significance. The problem is that any 
relationship between body (or brain) temperature, particularly 
with respect to sub-normal temperature and outcome is con-
founded by other important variables such as brain injury sever-
ity, age, gender, peripheral trauma, and a number of co-existing 
physiological responses (e.g., pupil size, intracranial pressure). At 
(b) Should therapeutic control of temperature be advocated as a 
treatment panacea or should it be “on prescription”?
manchester consensus meetIng
A cadre of clinician-scientists were invited to participate in a 
debate about the clinically relevant, but often controversial issue: 
“Is raised brain temperature; good or bad after human TBI?” 
Interlinked, “bench to bedside” lectures, were presented followed 
by workshop discussions, the content of which forms this consensus 
document.
lIterature framework
what are the PossIbIlItIes for accurate measurement of 
temPerature In PatIents?
The essential background role that calibration, traceability and 
accreditation play in ensuring reliable temperature measurement 
was discussed. Particular emphasis was given to ensuring measure-
ments were reliably linked to the International temperature scale 
of 1990 (ITS-90; Preston-Thomas, 1990). ITS-90 is essentially a 
“recipe” of how to realize a temperature scale that is close to thermo-
dynamic values through the calibration of specified thermometers 
(platinum resistance thermometers, PRTs) at defined temperature 
references known as fixed points. The primary fixed points are gen-
erally the freezing points of pure materials or triple points (e.g., of 
water). A triple point is a unique point on a materials phase diagram 
where solid, liquid, and vapor coexist. The calibrated PRT is then 
used as a reference for the calibration of other more “practical” 
sensors, e.g., in situ mini sensors of the type used in everyday health 
care practice. In addition, special radiance sources are constructed 
to derive their temperature from calibrated PRTs. These can be used 
to calibrate clinical infra-red (tympanic, temporal artery, thermal 
imaging) thermometers.
Using the triple point of two high performance organic fixed-
point temperature reference substances, Diphenyl-ether (DPE; 
nominally 26°C), and ethylene carbonate (EC; nominally 36°C), 
(both substances having temperature uncertainties of 0.005°C) the 
performance (reliability, reproducibility, and measurement error) 
of clinical thermometers used for deep body temperature measure-
ment were tested for traceability of the thermometers to ITS-90 
and for maximum confidence in the measurements. The results 
showed that all the temperature sensors tested (brain and core body 
thermistors) performed within the manufacturer’s stated tolerances 
(Childs and Machin, 2009; Machin and Childs, 2010).
In recent years, new techniques have emerged for non-invasive 
temperature measurement. Proton magnetic resonance spectros-
copy (1HMRS) can be utilized for absolute internal temperature 
(Childs et al., 2007). However, there is currently no established 
approach to calibrate measurements in a systematic way but two 
independent temperature measurement techniques can be used 
for MR thermometry: PRTs and phantom-based, organic triple 
point, temperature cells. Early results and field trials are promis-
ing (Vescovo et al., 2010). A novel, quasi-spherical, temperature 
phantom has been developed and built suitable for use at field 
strengths of 1.5 and 3 Tesla “phantom” material is placed at the 
center, surrounded by a reference source of the organic fixed-
point material, which for clinical measurement consists of either 
DPE or EC.
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difference in coagulation parameters (although a tendency toward 
lower platelet counts was observed in the hypothermic group) com-
pared to normothermic patients (Tokutomi et al., 2004).
PyrexIa: how does It Influence braIn oxygenatIon and 
chemIstry?
Altered temperature is a sign of inflammation rather than a dis-
ease itself. What seems certain in the light of the recent studies is 
that high temperature after TBI is common, especially in those 
presenting with a GCS of 9 or less (Stocchetti et al., 2002). The 
threshold for fever has been widely debated but practice param-
eters for evaluating new fever onset in critical care developed by 
O’Grady et al. (1998) allow a level of uniformity in describing fever. 
Stocchetti et al. (2005) show that 78% of patients had temperatures 
above 38.3°C, the Critical Care Society threshold for fever, despite 
antibiotic and antipyretic treatment. Pyrexia had a significantly 
different distribution depending on the severity of damage, with 
patients with the most severe brain trauma more likely to have 
an early and consistent pyrexia than those patients with GCS >8. 
Pyrexia prolonged the length of ICU stay (LOS).
For apyrexial patients, LOS was an average of 8 days whereas 
pyrexial patients stayed in ICU for significantly longer (average 
14 days). An important concern with regard to the impact of raised 
temperature after TBI is that of effects on intracranial pressure (ICP). 
Although Rossi et al. (2001) were unable to show a clear relationship 
between average ICP and brain temperature (a finding supported 
recently from the groups of LeRoux’s (Spiotta et al., 2008) and Childs 
et al. (2009) it was noted, that during the febrile episode, ICP was 
significantly increased. That a rise in brain temperature during fever 
was accompanied by a rise in ICP (and concomitant increase in 
SjO
2
) may suggest that the increase in brain temperature has effects 
more on increasing CBF (and possibly cerebral blood volume) than 
it does on increasing cerebral metabolism (CMRO
2
). The limited 
number of patients studied and the lack of direct cerebral blood 
flow monitoring make it possible only to suggest (from the SJO
2
 
measurements) that a mismatch between CBF and CMRO
2
 may be 
occurring during fever. Of course the rise in ICP and temperature 
may be epiphenomenon of different inflammatory processes or due 
to effects of raised temperature per se, possibly due to mechanisms 
other than “true” fever. Here “central” fever or neurogenic hyper-
thermia due to damage to the central thermoregulatory pathways 
may precipitate cerebral oedema as temperature exceeds 40°C. As 
Cremer and Kalkman (2007) suggest, neurological abnormalities of 
a temperature increase above the fever threshold, which has long 
been regarded to be 41°C (DuBois, 1949), is associated with dis-
turbed conscious level, brain oedema, and a high mortality. The 
possibility of a combination of pathological events linking raised 
temperature with brain swelling and intracranial hypertension has 
been observed in rodents (Sharma and Hoopes, 2003).
Significant reductions in mean brain tissue oxygen content (PbtO
2
) 
occur as brain temperature is lowered from 37°C to 34°C. Gupta 
et al. (2002) however show that at temperatures within the normal 
to moderate fever range (37–38.9°C) PbtO
2
 is relatively unchanged. 
More recent data lends further support to the view that raised brain 
temperature does not bring about a reduction in brain tissue oxygen 
(Spiotta et al., 2008). Using commercially available systems (Licox, 
Integra Neuroscience, Plainsboro, NJ, USA) for brain tissue partial 
the time of admission, approximately 10% of patients present-
ing with TBI were hypothermic (McHugh et al., 2007). From 
results of the International TBI data collaboration on modeling 
prognostic indicators of outcome after TBI (IMPACT; Maas et al., 
2007), it was recognized that any relationship between (brain) 
temperature and outcome would be confounded by other impor-
tant variables (if not measured and adjusted for). During the years 
spanning 1982–1998, the IMPACT methods were to merge data 
from randomized trials and large observational studies of TBI 
patients treated in an ICU setting. Univariate analysis of 26 pre-
dictors for outcome at 6 months were analyzed in 8719 patients. 
Hypoxia, hypotension, and spontaneous hypothermia were sig-
nificant prognostic markers of adverse outcome. However, the 
strength of the association between hypothermia on admission 
to the Emergency Department (ED) and adverse outcome after 
TBI was lessened after adjustment for other confounders such as 
age, GCS, motor score and pupil size and reactivity. In view of 
the results, the adverse outcomes associated with spontaneous 
hypothermia do not lend support for “continued” body cooling 
of the TBI patient on arrival to the ED and before transfer to ICU. 
Despite the large numbers of patients studied from the IMPACT 
database, there is still uncertainty about how best to manage body 
temperature after acute TBI.
Is theraPeutIc hyPothermIa a double-edge sword?
From studies of experimental ischemia in rodents, the mechanisms 
of neuroprotection by hypothermia appear to be multifactorial. The 
degree of neuroprotection afforded will depend on the severity of 
the insult and the timing, depth and duration of hypothermia after 
the onset of cerebral ischemia. As the pathological mechanisms 
involved are known to be complex, they may of themselves act as a 
double-edged sword, having both beneficial and deleterious effects 
on the ischemic animal brain (Endress et al., 2008). Of the bio-
chemical pathways involved in “hypothermia-induced neuropro-
tection,” glutamate and calcium ions are major players in neuronal 
excitotoxicity but they are also essential for normal brain function 
and a key driving force for the reorganization and synaptogenesis 
involved in tissue repair after injury (Wieloch and Nikolich, 2006). 
In this same vein, nitric oxide (NO) derived from endothelia may 
increase blood flow, so aiding healing, whilst neuronal and induc-
ible NO synthase (NOS) may contribute to inflammation with 
the formation of oxidants and free radicals. This raises questions 
about whether or not hypothermia (which may act to ameliorate 
inflammation) is exclusively beneficial. Perhaps at times hypother-
mia could be disadvantageous (Goss et al., 1995). Hypothermia 
might be protective early during recovery but if induced later, might 
impede repair.
From the point of view of effects on coagulation, hypothermia 
is regarded as a major risk factor for morbidity and mortality. It is 
a well recognized supposition that free blood in the ventricles after 
subarachnoid hemorrhage may play a role in vasospasm and devel-
opment of high fever (Grande et al., 2009). However, whilst experi-
mental hypothermia (32°C) has been shown to inhibit coagulation 
function in swine (Martini, 2007) and in hypothermic (33.8°C) 
post-laparotomy surgical patients with blood loss (Bernabei et al., 
1992) the induction of hypothermia after severe TBI in patients with 
comparable (33°C) body temperature did not show a significant 
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braIn temPerature and outcome after tbI: tracIng the 
evIdence from bench
Although new possibilities for non-invasive temperature meas-
urement are on the horizon, the day to day delivery of accurate 
estimation of body, and in the case of brain trauma, brain tissue 
temperature, remain one of the most common clinical measurement 
activities. Despite the interest in temperature and outcome after TBI, 
there is no universal definition of the threshold for an increased tem-
perature or where and how temperature should be measured. The 
European Brain Injury Consortium guidelines recommend avoiding 
hyperthermia but do not define this (Maas et al., 1997). The most 
recent Brain Trauma Foundation Guidelines do not mention fever 
thresholds or discuss the management of increased temperature 
[except in the context of hypothermia (level III recommendation 
only); Cook et al., 1995]. In practice most clinicians contend that 
normothermia is beneficial after TBI and, anecdotally, in the view 
of some, therapeutic hypothermia is warranted. However, Aiyagari 
and Diringer in a recent systematic review of fever control in brain 
injury concluded that: “… the answer to the critical question: Does 
fever control improve outcome is not known?”. The definitive study 
has not been performed (Aiyagari and Diringer, 2007). Two recent 
systematic reviews of therapeutic hypothermia for TBI have not 
shown clear benefit (Peterson et al., 2008; Sydenham et al., 2009). 
On this basis, decisions about how best to approach the management 
of temperature have not achieved equipoise.
Even so, current opinion is that raised temperature after TBI is 
associated with worse outcome. There is some support for this view 
in a recent systematic review and meta-analysis on pooled data from 
patients with stroke and TBI (Greer et al., 2008). However, only 17% 
of the patient cohort had TBI. Of the eight adult TBI studies, four 
failed to show a significant relationship between temperature and 
mortality (Jeremitsky et al., 2003; Geffroy et al., 2004, (and Glasgow 
Outcome Score, GOS), Andrews et al., 2002; Soukup et al., 2002). 
The relationship between temperature and outcome after TBI may 
not be entirely clear cut as shown recently in an observational study 
of the relationship between temperature and outcome in patients 
with severe TBI (Childs et al., 2006).
In the relationship between temperature and outcome there 
are potentially confounding factors such as severity of injury 
(Jeremitsky et al., 2003) and, because temperature is a symptom, 
pressure of oxygen overall brain temperature and brain tissue oxy-
gen were poorly correlated suggesting that the relationship between 
human brain temperature and brain oxygen is complex.
Against this background of uncertainty about the role of raised 
temperature; whether it could be harmful to injured neurones or 
whether it could be an adaptive response and therefore of some 
benefit to the patient, the impact of pyrexia on neurochemistry 
and cerebral oxygenation after acute brain injury was presented. 
Brain tissue temperature, partial pressure of oxygen (Licox Systems, 
Integra Neurosciences, Plainsboro, NJ, USA) and microdialysis 
(CMA, Sweden) for brain glucose, lactate, pyruvate, and glutamate 
were measured in a mixed neurocritical care population. Despite 
a rise in brain temperature of the order of 1.3°C, no significant 
changes from baseline in any of the measured variables (including 
ICP, CPP, brain tissue pH, CO
2
, glucose, lactate, pyruvate, ratio) 
were observed. However it was noted that brain tissue oxygen partial 
pressure (reflecting the balance between cerebral oxygen delivery 
and consumption) rose significantly and the arterio-venous differ-
ence in oxygen content (AJDO
2
) dropped significantly from 4.2 to 
3.8 vol% (p < 0.05). These data suggest that oxygen supply to the 
brain during fever in patients with non-ischemic brain trauma (TBI) 
remains adequate during the febrile event.
Appropriate, and safe, translation of research evidence obtained 
in experimental studies to the patient is of key importance for 
evidence-based practice (Sacho and Childs, 2008). Despite the 
weight of opinion that raised temperature is both frequent and 
harmful, results from Stocchetti’s group showing that a rise in aver-
age brain temperature (from 38 to 39°C) was not associated with 
abnormal neurochemistry requires an explanation particularly as 
pyrexia appeared to be well tolerated in the small patient popula-
tion studied and, furthermore, did not exacerbate ICP readings 
(Table 1). This is of particular importance currently, in view of 
the recent evidence that many of the treatments used to lower the 
temperature of the body are associated with adverse side effects 
(Seule et al., 2009). In the current clinical climate, translational 
medicine is pivotal in establishing: (a) whether results obtained 
in one clinical pathology (e.g., stroke) translate to other clinical 
conditions (e.g., severe brain trauma) and (b) whether studies in 
animals are an appropriate model for safe translation of results 
from the bench to the bedside.
Table 1 | Changes in intracranial pressure, cerebral perfusion pressure, pH, and jugular bulb oxygen saturation before and after the development of 
pyrexia.
 Fever onset Fever lysis
 ICP CPP PbtO2 pHbr SJO2 ICP CPP PbtO2 pHbr SJO2 
 (mmHg) (mmHg) (mmHg)   (mmHg) (mmHg) (mmHg)  
Baseline (Tbr 38.0°C) 16 (4) 71 (10) 32 (21) 7.19 (0.06) 0.69 (0.05)     
Pyrexia (Tbr 39.3°C) 17 (6) 71 (100) 37 (22)* 7.16 (0.06) 0.71 (0.06)     
Pyrexia (Tbr 39.2°C)      18 (6) 71 (6) 24 (14) 7.10 (0.09) 0.70 (0.05)
Baseline (Tbr 38.0°C)      16 (5)** 72 (8) 25 (18) 7.13 (0.09)** 0.67 (0.08)*
Table adapted from Stocchetti et al. (2005)
Data (baseline to fever onset, n = 14). Data expressed as mean (SD)
Changes in Tbr, intraparenchymal brain temperature; ICP, intracranial pressure; CPP, cerebral perfusion pressure; PbtO2, brain tissue oxygen content; pHbr, brain tissue 
Ph; and SJo2, jugular saturation at the superior jugular bulb in 13 patients with severe TBI before (baseline) and on developing fever (pyrexia).
*p < 0.05 vs baseline, ** p < 0.001 vs pyrexia. Note the significant increase in PbtO2 with pyrexia.
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et al. (2006) (Figure 2), used logistic regression to explore for lin-
ear and quadratic relationships between initial (and 48 h average) 
brain temperature and survival at 3 months. No evidence of an 
association between initial brain temperature and risk of death was 
found. From statistical modeling, and assuming a linear relation-
ship between brain temperature and death at 3 months, patients 
with higher mean brain temperature were less likely to die OR (95% 
confidence interval, CI) for death per 1°C change in temperature 
was 0.31 (0.09–1.1, p = 0.06). On the other hand, fitting a quadratic 
relationship to the data suggested that low and high end tempera-
tures were associated with an increased risk of death. Unlike studies 
in human stroke where high admission temperature predicts poor 
outcome (Reith et al., 1996), results in a population of severe TBI 
patients did not support such a relationship.
In our subsequent study of the temporal pattern of brain tem-
perature, 35 of 67 patients with severe TBI had a brain temperature 
>37.5°C for 60–100% of time during the first 5 days. Therapeutic 
temperature management with body cooling was minimal. There 
were four deaths only (11%) in this “persistent pyrexia” group. More 
patients died in the group who did not develop pyrexia. Statistical 
modeling of the relationship between brain temperature and prob-
ability of death at 30 days revealed the lowest probability of death 
to be in patients with brain temperature in the range 36–38.5°C. 
Taking in to account the severity of brain injury using pupil size and 
reactivity as a marker, the predicted probability of death increased 
as brain temperature dropped below 36°C. For those patients with 
“abnormal” pupillary responses, the probability of death was rather 
constant across the range 34–39°C (Sacho et al., 2010). Small sam-
ple size limits the impact of the findings but even so, the results 
do raise important questions; not least the question of whether a 
the reason(s) for a rise in temperature may include the acute 
inflammatory response to injury, infection and/or neurogenic 
fever (Thompson et al., 2003). The problem is that the underlying 
cause of raised temperature may be impossible to determine with 
certainty. Furthermore, there is likely to be a complex interplay 
with other influences on temperature, for example hypotension, 
blood sugar, hydration, and sleep (Mekjavic and Eiken, 2006). 
Adding to the complexity of probing the root to the relation-
ship between temperature and outcome is the variability in tem-
perature site, the frequency of the measurement interval per se, 
the duration of temperature monitoring, the frequency of raised 
(or lowered) temperature, the use of therapeutic temperature 
interventions and the time-interval to follow-up and outcome 
assessments.
Decision tree analysis has been used to explore predictors of 
outcome at 12 months (Jones et al., 1994; McQuatt 1998; Andrews 
et al., 2002). Logistic regression analysis in a patient sub-set showed 
duration of pyrexia to be significantly associated with mortality at 
12 months (p = 0.014; Jones et al., 1994). However the decision tree 
analysis for GOS prediction showed a small group of patients in 
whom “more” pyrexia was not associated with worse outcome, nor 
“less” pyrexia with better outcome (McQuatt, 1998). The emerg-
ing hypothesis from some of the decision trees is that pyrexia may 
not always be detrimental. Further assessment and investigation 
is warranted (Andrews et al., 2002).
These results are supported by data from our own group (CC) 
where burden of pyrexia (% time spent with brain temperature 
≥37.5°C) during the period of intraparenchymal monitoring was 
significantly greater in survivors compared with non-survivors 
(p = 0.02; Figure 1). In the first of two observational studies, Childs 
FIgure 1 | Percentage (%) time during the period of neuro-monitoring 
that patients with severe TBI (n = 36) had brain temperature ≥37.5°C. 
Figure shows data from survivors (O) and non-survivors (∆) plotted with 
respect to standard deviation of mean brain temperature.
FIgure 2 | The initial brain temperature (°C) at time of insertion of 
combined intracranial pressure/temperature sensor (left column) and 
mean brain temperature measured during the first 48 h after injury (right 
column) in 37 patients with severe TBI admitted to ICu for medical 
management of their brain injury. Symbols represent survivors (O) and 
non-survivors (+). (Reproduced with permission).
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(b) Should therapeutic control of temperature be advocated as a 
treatment panacea or “on prescription”?
From the discussions, the participants arrived at a level of 
 agreement for each issue and the summary opinion provided the 
basis for this consensus document (Table 2).
The conclusions drawn from the meeting were: there is, as yet, 
no robust scientific data to support the use of therapeutic control 
of temperature by induction of hypothermia in patients whose 
ICP is controllable using standard therapy. A randomized clinical 
trial is justified to establish if body cooling for control of pyrexia 
(to normothermia) vs moderate pyrexia leads to a better patient 
outcome for TBI patients.
1–2°C rise in temperature commonly thought to cause secondary 
injury in the damaged (ischemic) brain is deleterious for all patients 
with severe TBI.
Process: questIons Posed at the roundtable 
workshoP
Having discussed the background literature and debated the role of 
temperature in the injured human brain, the participants worked 
together in four groups to discuss two issues relevant to neurocriti-
cal care management after TBI:
(a) What should future recommendations for temperature mea-
surement be: direct measurement of brain temperature or 
body core temperature surrogates?
Table 2 | Summary of workshop discussions and the participants’ recommendations and consensus.
Workshop objective Discussion points Concerns expressed recommendations Consensus
To discuss future 
recommendations for 
temperature 
measurement in 
patients with severe 
TBI.
Do opportunities exist 
for improvement in 
measurement accuracy?
What are the range of 
differences between 
brain and body 
temperature and how 
much do they vary?: see 
Kirk et al. (2009)
What are the benefits of 
brain temperature 
monitoring?
Value of common body 
temperature sites (Johnston et al., 
2006; axilla/skin folds/rectal/
oesophageal) as surrogates for 
brain temperature should be 
questioned due to poor 
measurement practice
No published guidelines available 
for standardization of depth (or 
positioning) of the brain 
temperature sensor
In view of evidence that 
differences exist between brain 
and body temperature, this should 
be sufficient justification for direct 
brain temperature monitoring
Need for improved 
measurement reliability in 
thermometry practice
Support for greater use of 
multi-modality monitoring
If the objective of 
neuro-monitoring is to 
prevent secondary 
damage-“normal” brain 
rather than “damaged” 
brain tissue should be the 
focus for monitoring
A possible benefit of brain 
temperature monitoring is 
the potential to “titrate” 
brain temperature to ICP
Standardization in temperature 
measurement is a key 
objective for the future
Lack of confidence in rectal 
temperature as a surrogate for 
brain temperature is attributed 
to poor measurement practice 
notably: site and depth of 
thermistor insertion.
Brain temperature monitoring 
should be encouraged as a 
“gold” standard if intracerebral 
monitoring is warranted
Goal for the future: to build a 
body of evidence on brain 
temperature about absolute 
and trend change differences 
between brain and different 
core sites
There is a need to understand 
the role of brain temperature as 
a biomarker for outcome
To discuss whether 
therapeutic control of 
temperature should be 
advocated as a 
treatment panacea or 
undertaken “on 
prescription”
What is the evidence 
that therapeutic control 
of body/brain 
temperature is beneficial 
for all neurosurgical 
patients?
The effect of not cooling patients 
with high brain temperature (i.e., 
>39°C) on survival of injured 
neurones is unknown.
Treatments/ therapies to 
manipulate brain/body temperature 
to normal/below normal, levels are 
justified only as an adjunct therapy 
for those patients with refractory 
intracranial hypertension where 
clinicians are “struggling” to gain 
control of pressure increases 
within the brain.
Overwhelming support was 
given to a more 
“prescriptive” or “tailored” 
approach to the use of 
cooling interventions 
Patients with refractory ICP 
may benefit from body 
cooling.
The “selection” of patients for 
therapeutic hypothermia was a 
preferred approach to 
temperature management
Whole body/internal cooling is 
not justifiable for temperature 
control per se.
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